Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Mimedx (MDXG) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Mimedx (MDXG) over the last 15 years, with Q3 2025 value amounting to $23.0 million.

  • Mimedx's Accumulated Depreciation & Amortization rose 801.2% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 801.2%. This contributed to the annual value of $21.3 million for FY2024, which is 646.1% up from last year.
  • As of Q3 2025, Mimedx's Accumulated Depreciation & Amortization stood at $23.0 million, which was up 801.2% from $22.4 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Accumulated Depreciation & Amortization ranged from a high of $37.9 million in Q3 2023 and a low of $20.0 million during Q4 2023
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $31.3 million (2021), whereas its average is $28.8 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first skyrocketed by 1789.75% in 2021, then crashed by 4425.36% in 2023.
  • Mimedx's Accumulated Depreciation & Amortization (Quarter) stood at $32.9 million in 2021, then increased by 9.27% to $35.9 million in 2022, then tumbled by 44.25% to $20.0 million in 2023, then rose by 6.46% to $21.3 million in 2024, then grew by 7.74% to $23.0 million in 2025.
  • Its last three reported values are $23.0 million in Q3 2025, $22.4 million for Q2 2025, and $21.9 million during Q1 2025.